CHAPTER 6 PSYCH3 Flashcards

(58 cards)

1
Q

irreversibly inhibit monoamine
oxidase, blocking metabolism of monoamine
neurotransmitters

A

MAOIs:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Indications of MAOI

A

atypical depression, panic disorder, social
phobia, posttraumatic stress disorder, OCD, bulimia
nervosa, pain management

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Severe hypertension and complications of malignant hypertension if taking MAOIs and _____

A

tyramine-containing substance or food is ingested

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

___________ if MAOIs taken in combination
with SSRIs or other antidepressants, over-the-counter
medications, meperidine, stimulants, sympathomimetics

A

Serotonin syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MAOI

better than SSRIs for ______
also used for insomnia, pain, obsessive-compulsive
disorder, panic, anxiety

A

melancholic depression,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Contraindications of MAOI:

A
recent myocardial infarction, 
bundle branch block, 
widened QRS,
 narrow-angle glaucoma,
cardiac disease, 
prostatic hypertrophy,
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mixed-mechanism antidepressants:

A

bupropion, duloxetine,

mirtazapine, nefazodone, trazodone, venlafaxine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Mechanism of Bupropion

A

Dopamine-NE reuptake inhibitor: preferentially
increases dopamine (weak inhibitor of dopamine
reuptake)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Clinical use of Buproprion

A

FDA-approved for depression,
smoking cessation;
non-FDA–approved—attention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Buproprion Can increase seizure risk at doses more than ________

A

450 mg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Contraindications of Buproprion: patients with ___ and _______

A

seizure disorders,

eating disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Duloxetine (Cymbalta) clinical use

A

Clinical uses: FDA-approved for depression, diabetic

peripheral neuropathic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Enhances release of NE and 5HT, inhibits 5HT2 and
5HT3 receptors, also potent histamine antagonist,
moderate α2-adrenergic antagonist

A

Mirtazapine (Remeron)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Indications for Mirtazapine (Remeron)

A

FDA-approved for depression; non-

FDA–approved—improves appetite and sleep

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

SE of Mirtazapine

A

early sedation, weight gain, possible

agranulocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Serotonin (5HT2) receptor-antagonist, weak
inhibitor of 5HT reuptake (5HT2 antagonist/reuptake
inhibitor

What anti-depressant

A

Nefazodone (Serzone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Serotonin (5HT2) receptor-antagonist, weak inhibitor
of 5HT reuptake (5HT2 antagonist/reuptake inhibitor

Clinical uses: FDA-approved for depression; non-
FDA–approved—insomnia

A

Trazodone (Desyrel)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Inhibits 5HT reuptake at lower doses, inhibits NE
reuptake at moderate doses, and dopamine reuptake
at higher doses

A

Venlafaxine (Effexor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Examples of Typical anti-psychotics

A

chlorpromazine (Thorazine), mesoridazine
(Serentil), thioridazine (Mellaril), fluphenazine
(Prolixin), perphenazine (Trilafon), trifluoperazine
(Stelazine), thiothixene (Navane), loxapine (Loxitane),
haloperidol (Haldol), molindone (Moban)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

1) Favorable side-effect profile (useful in emergency
settings)
2) Useful for positive symptoms but not negative symptomsof schizophrenia
3) High potential for dose-dependent acute extrapyramidalside effects and sexual dysfunction

A

Haloperidol: high-potency agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

_________ also has potential to cause retinitis pigmentosa, retrograde ejaculation, QTc prolongation

A

Thioridazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

1) Effective for positive symptoms, less effective for negative symptoms of schizophrenia
2) Has a relatively favorable risk versus benefit ratio, so is
widely used

A

Thiothixene, perphenazine, trifluoperazine: medium

potency agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Atypicals: _____________

A

clozapine, risperidone, olanzapine, quetiapine,

aripiprazole, ziprasidone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Clozapine (Clozaril): low-potency agent, for _____

1) Choice for patient with______ and ____
2) Effective for ____ and _____ symptoms of
schizophrenia
3) Should have had at least three failed trials of antipsychotics from different classes and at least one depot formulation trial

A

refractory schizophrenia

tardive dyskinesia or at high risk for tardive dyskinesia
positive and negative

25
Serious side effects of Clozapine:
agranulocytosis, seizures
26
Risperidone (Risperdal): high-potency agent 1) Effective for ______ and ______ symptoms of schizophrenia 2) Reduced potential for acute or chronic extrapyramidal side effects 3) Can significantly increase serum _______, more _________ is possible
positive and negative prolactin levels sexual dysfunction
27
1) Is structurally similar to and acts like clozapine but with less risk for agranulocytosis and seizures 2) Acute extrapyramidal side effects no more frequent than reported for placebo, low chance for chronic extrapyramidal side effects
Olanzapine (Zyprexa): medium- to high-potency agent
28
SE of Olanzapine
weight gain, hypertriglyceridemia, sedation, | diabetes (?) , elevated liver function enzymes
29
low potency, few EPS, less | sexual dysfunction, no prolactin increase antipsychotic
Quetiapine (Seroquel)
30
Antipsychotics Typicals bind to _______, blocking dopamine at the site, more prone to extrapyramidal side effects
D2 receptors
31
Antipsychotics Atypicals are weaker D2 receptor antagonists but are potent ______ receptor antagonists and also have ______ and ______
5HT2A anticholinergic and antihistaminic activity
32
______ and _____dopaminergic pathways | are affected by antipsychotics
Mesocortical and mesolimbic
33
Adverse effects of anti-psychotics _____________- abnormal involuntary movements (usually mouth and/or tongue) after long-term use -Elderly, women, and those with mood disorders more susceptible
Tardive dyskinesia:
34
Adverse effects of anti-psychotics __________ (tremor, rigidity, hypokinesia): treat by lowering dose of antipsychotic or adding antiparkinsonian agent
Parkinsonism
35
Adverse effects of anti-psychotics ______ (subjective feelings of anxiety, tension, agitation): treat by lowering dose of antipsychotic, try β- blocker, clonidine, amantadine, or benzodiazepine
Akathisia
36
Adverse effects of anti-psychotics sustained contraction of muscles of neck, mouth, tongue): treat with intravenous benztropine or diphenhydramine
Acute dystonic reaction
37
Adverse effects of anti-psychotics ________ (dry mouth, urinary retention, blurry vision, constipation, exacerbation of narrowangle glaucoma): treat by reducing dose or change to more potent antipsychotic or to atypical antipsychotic
Anticholinergic side effects
38
Adverse effects of anti-psychotics Agranulocytosis (associated with low-potency antipsychotics and especially clozapine; potentially fatal): requires weekly blood counts for_____ and ____
first 6 months, then | every 2 weeks thereafter
39
Adverse effects of anti-psychotics rigidity, high fever, delirium, autonomic instability, increased serum levels of creatine kinase and liver enzymes): treat by stopping offending drug, supportive care, try dantrolene or bromocriptine, ECT for severe cases
Neuroleptic malignant syndrome
40
Rapid removal of medications with dopaminergic properties such as those used to treat _______ can also cause neuroleptic malignant-like syndrome
Parkinson’s disease
41
________: most often prescribed psychotropic | medications
Anxiolytics
42
BZD with long half life
``` chlordiazepoxide (Librium), clonazepam (Klonopin), clorazepate (Tranxene), diazepam (Valium), flurazepam (Dalmane ```
43
BZD with Medium half-life:
estazolam (ProSom), lorazepam | Ativan), temazepam (Restoril
44
BZD with Short half-life:
alprazolam (Xanax), oxazepam (Serax), | triazolam (Halcion)
45
Preferred benzodiazepines for the elderly:
oxazepam, | lorazepam, temazepam (“out the liver”)
46
anxiolytics, sedative-hypnotics 1) Used for generalized anxiety disorder: effects seen after 1 to 2 weeks 2) Relatively nonsedating, no abuse potential
Buspirone (BuSpar)
47
Electric current applied across scalp electrodes, producing a grand mal seizure
ECT
48
ECT may improve both mood and motor symptoms of patients with _______, but effects may be short-lived from days to weeks to 6 months, according to various studies
advanced Parkinson’s disease
49
MOA of Lithium
inhibits inositol-1-phosphatase
50
Indications of Lithium therapy
mania, augmentation of antidepressants, prophylaxis of mania/depression, schizoaffective disorder, aggression, impulsivity
51
Concerns for Lithium:
thyroid/kidney, pregnancy (Ebstein’s | anomaly
52
Clinical indications for Amphetamine:
1) Narcolepsy and other sleep disorders, attentiondeficit/ hyperactivity disorder in children, obesity 2) Has also been used for depression by augmenting antidepressant effects, neurasthenia, AIDS dementia, encephalopathy from brain injury
53
MOA of Amphetamine
1) Causes direct release of dopamine and NE from neurons 2) Blocks reuptake of catecholamines 3) Peak plasma levels in 1 to 3 hours
54
___________ related to amphetamine, but milder stimulant (little or no abuse potential)
Methylphenidate (Concerta, Ritalin):
55
________ novel stimulant for narcolepsy
Modafinil (Provigil):
56
Sympathomimetics decrease efficacy of many antihypertensive | agents, especially ______ and _______
guanethidine (Ismelin) and | guanethidine-hydrochlorothiazide (Esimil)
57
Techniques for behavioral therapy
classic conditioning, operant conditioning, positive reinforcers, negative reinforcers, relaxation training, systematic desensitization, flooding, behavioral modification
58
a person’s evaluation of a perceived adverse event largely determines the degree and type of emotional state experienced
Cognitive-behavioral therapy: